Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Gross Margin (2021 - 2025)

Historic Gross Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 65.16%.

  • MDxHealth's Gross Margin rose 39400.0% to 65.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.48%, marking a year-over-year increase of 27500.0%. This contributed to the annual value of 61.23% for FY2024, which is 13500.0% down from last year.
  • Latest data reveals that MDxHealth reported Gross Margin of 65.16% as of Q3 2025, which was up 39400.0% from 66.03% recorded in Q2 2025.
  • MDxHealth's Gross Margin's 5-year high stood at 66.03% during Q2 2025, with a 5-year trough of 46.35% in Q4 2021.
  • For the 5-year period, MDxHealth's Gross Margin averaged around 58.05%, with its median value being 59.96% (2024).
  • Per our database at Business Quant, MDxHealth's Gross Margin surged by 130900bps in 2023 and then tumbled by -36500bps in 2024.
  • Over the past 5 years, MDxHealth's Gross Margin (Quarter) stood at 46.35% in 2021, then grew by 21bps to 56.04% in 2022, then grew by 17bps to 65.32% in 2023, then decreased by -4bps to 62.72% in 2024, then grew by 4bps to 65.16% in 2025.
  • Its Gross Margin stands at 65.16% for Q3 2025, versus 66.03% for Q2 2025 and 63.82% for Q1 2025.